Latest Breaking News On - பெர்ரி நிறுவனம் பொது உறவுகள் - Page 14 : comparemela.com

Cell and Gene Therapy Innovator Castle Creek Biosciences Appoints Matthew Gantz as President and Chief Executive Officer

Cell and Gene Therapy Innovator Castle Creek Biosciences Appoints Matthew Gantz as President and Chief Executive Officer - Life sciences executive brings more than 25 years of experience to cell and gene therapy company progressing through pivotal Phase 3 clinical trial - News provided by Share this article Share this article EXTON, Pa., April 20, 2021 /PRNewswire/ Castle Creek Biosciences, Inc. (the Company ), a privately held, clinical-stage cell and gene therapy company leveraging its proprietary fibroblast technology platform to develop and commercialize disease-modifying therapies for patients suffering from orphan conditions for which there is a lack of available treatment options, today announced that Matthew Gantz has been appointed President and Chief Executive Officer. He will also serve as a member of the Company s Board of Directors. Mr. Gantz succeeds John Maslowski, who will continue to serve the company as Chief Operating Officer.

United statesMatthew gantzAdam daleyKaren caseyJeff aroninJohn maslowskiEmalex biosciencesCompany board of directorsPrinceton universityMarine corps scholarship foundationHarvard business schoolCastle creek biosciences incBerry company public relationsChiron corporationAcureon pharmaceuticals incAbbott laboratories

Memic Innovative Surgery Raises $96 Million

Memic Innovative Surgery Raises $96 Million USA - English Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed Funding primarily supports commercialization of Hominis® surgical robot in the United States following FDA De Novo marketing authorization News provided by Share this article Share this article TEL AVIV, Israel and FORT LAUDERDALE, Fla., April 12, 2021 /PRNewswire/ Memic Innovative Surgery (Memic), a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced the closing of a $96 million Series D financing. The financing round was led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding will support commercialization of the Hominis® robotic-assisted surgical platform in the U.S. and potentially in other countries around the world as the company also plans to expand marketing and sales efforts outside the U.S. The financing will

Tel avivEyal lifschitzMark goldwasserLynn granitoMauricer ferrDvir cohenBerry company public relationsMako surgical incDrug administrationMemic innovative surgeryPeregrine venturesFort lauderdaleMako surgicalதொலைபேசி அவிவ்குறி கோல்ட்வாசர்லின் கிரானிடோ

Rhythm Pharmaceuticals, Inc : Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference BOSTON, April 07, 2021 (GLOBE NEWSWIRE) Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the 20 th Annual Needham & Co. Virtual Healthcare Conference on Wednesday, April 14, 2021 at 11:45 a.m. ET. A live audio webcast of the presentation will be available under Events & Presentations in the Investor Relations section of the Company s website at www.rhythmtx.com. A replay of the webcast will be available on the Rhythm website for 30 days following each presentation.

United statesAdam daleyHannah deresiewiczDavid meekerDavid connollyStern investor relations incRhythm pharmaceuticalsExchange commissionRhythm pharmaceuticals incNeedham coBerry company public relationsCorporate communicationsChief executive officerAnnual needhamVirtual healthcare conferenceInvestor relations

Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan

Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaScott durbinBill berryDrug administrationViveve incTaiwan intellectual property officeViveve medical incBerry company public relationsSecurities exchangeDynamic medical technologies incViveve medicalTaiwan patentMedical technologiesCryogen cooled monopolar radiofrequencyClinical advisory board

Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update

Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaBill berryScott durbinBerry company public relationsSecurities exchangeDrug administrationViveve incViveve medical incViveve medicalAsia pacificRecent businessClinical advisory boardCryogen cooled monopolar radiofrequencySecurities actSecurities exchange act